The GLP is committed to full transparency. Download and review our 2019 Annual Report

Indiana fish farm will grow genetically engineered AquAdvantage salmon in 2018

| | April 4, 2018
SIS Aquaculture
Indiana fish farm will grow genetically engineered AquAdvantage salmon in 2018
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

A biotechnology company is upgrading a defunct fish farm where it plans to grow AquAdvantage Salmon — the first genetically engineered animal for human consumption as food.

The company is building a 250-metric ton (551,156 pounds annually) production unit in Rollo Bay, Prince Edward Island, Canada, and is upgrading the former Bell Aquaculture fish farm in Albany [Indiana] to increase production to 1,200 metric tons (2,645,547 pounds) a year.

“Both of these facilities must be approved by the FDA (U.S. Food & Drug Administration) prior to their initial stocking with AquAdvantage Salmon, but we anticipate both to be operational in 2018 with a first harvest of commercial production in late 2019,” the company reported.

AquAdvantage Salmon integrates a Pacific Chinook salmon growth-hormone gene into the genome of an Atlantic salmon. The Chinook gene is under the control of a “promoter” from an eel-like fish called an ocean pout.

The FDA determined in 2015 that AquAdvantage Salmon was as safe to eat as non-genetically engineered salmon….

AquAdvantage Salmon grow to market size faster than conventional Atlantic salmon and require less feed.

Read full, original post: Genetically engineered salmon farm in Albany underway

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend